Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical exporter from India, supplying Doxorubicin Hydrochloride Liposomal Injection 20mg/50mg to international markets with a commitment to quality, affordability, and timely delivery.
We proudly serve healthcare distributors, hospitals, oncology centers, government tenders, and pharmaceutical importers across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What is Doxorubicin Hydrochloride Liposomal Injection?
Doxorubicin Hydrochloride Liposomal Injection is an advanced liposomal formulation used in cancer treatment. Liposomal technology helps deliver the medicine more effectively while reducing certain toxic effects associated with conventional doxorubicin.
Indications (Used Under Medical Supervision)
Doxorubicin Hydrochloride Liposomal Injection may be prescribed for:
Ovarian Cancer treatment
Metastatic Breast Cancer treatment
Multiple Myeloma (in combination therapy)
AIDS-related Kaposi's Sarcoma
Advanced oncology treatment protocols
Important: This medicine must be administered only by qualified healthcare professionals experienced in chemotherapy administration.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
✅ WHO-GMP compliant manufacturing partners
✅ Reliable oncology medicine exporter from India
✅ International quality standards
✅ Competitive wholesale pricing
✅ Bulk supply for hospitals and government tenders
✅ Fast global logistics support
✅ Export documentation assistance
✅ Dedicated B2B pharmaceutical export team
Countries We Export To
🌍 Africa
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇿🇦 South Africa
🌏 Asia
🇵🇭 Philippines
🇻🇳 Vietnam
🇦🇪 UAE
🇸🇦 Saudi Arabia
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
🌎 Europe & North America
🇬🇧 UK
🇺🇸 USA
